OPIOID USE DISORDER (OUD) TREATMENT IN A PATIENT CENTERED HEALTH CENTER
|
|
- Dinah French
- 5 years ago
- Views:
Transcription
1 OPIOID USE DISORDER (OUD) TREATMENT IN A PATIENT CENTERED HEALTH CENTER Ed Johnson M.Ed., MAC, LPC, CCS Associate Director, Training & Technical Assistance Southeast Addiction Technology Transfer Center (Southeast ATTC) edjohnson@msm.edu
2 LEARNING OBJECTIVES Increase understanding of Substance Use Disorders (SUD) as a chronic medical condition. Become familiar with the stigma of SUD and the concurrent discrimination people with Opioid Use Disorder (OUD) experience. Discuss how our language reflects our concepts of SUD Treatment and Recovery and impacts Stigma
3 We Can t Fight This Epidemic Without Removing Stigma President Barack Obama Charleston, West Virginia October 21, 215
4 STIGMA Stigma A mark of disgrace or infamy associated with a particular circumstance, quality or person.
5 CELEBRITY ADDICTION When the actor Phillip Seymour Hoffman died the description was found half naked on the bathroom floor with a needle hanging out of his arm. If that had been a heart attack would they have said half naked on the bathroom floor with a BigMac in his hand and French fries scattered across the floor? 5
6 LEVELS OF STIGMA Legal vs. Illicit Type of illicit substance used Method of Use
7 SHAME A painful feeling of humiliation or distress caused by the consciousness of wrong or foolish behavior. It is differentiated from guilt in that guilt involves a behavior, shame involves the intrinsic sense of one s self. Guilt- I behaved badly; Shame I am bad.
8 THE POWER OF WORDS TO HURT OR HEAL Stigmatizing Words Addict, Abuser, Junkie, User Relapse Substance Abuse / Prescription Drug Abuse Alternative Terminology Person in active addiction, person with a substance use disorder, person experiencing an alcohol/drug problem, patient /client, person served Recurrence / return to use Substance Use Disorder, Prescription Drug Misuse Clean, Dirty Replacement or Substitution Therapy Negative, positive/ Drug free, Free from illicit and nonprescribed medication Treatment, medication-assisted treatment, medication The Rhetoric of Recovery Advocacy: An Essay On the Power of Language W.L.White; E.A Salsitz, MD., Addiction Medicine vocabulary; Substance Use Disorders: A Guide to the Use of Language Prepared by TASC, Inc. Center for Substance Abuse Treatment (CSAT), Substance Abuse and Mental Health Services Administration (SAMHSA), part of the U.S. Department of Health and Human Services (DHHS), rev
9 OTHER WORDS OR CONCEPTS WE SHOULD THINK ABOUT Drug of Choice Denial Clean and Sober Victims
10 THOSE PEOPLE Alcoholic Addict Drunk Old Wino Crack Head Junkie Needle Freak Benzo Queen Garbage Head Burn Out Pot Head Borderline Nut Job Crazy And then there is Chronic Relapser
11 THE LANGUAGE THAT WE USE They re not ready They don t want it bad enough They haven t hurt/lost enough They re too resistant They are in denial
12 WHAT IS ADDICTION?
13 Is it willful misconduct or Is it a Medical Condition?
14 We know from the research that has been conducted by some of the worlds leading neuroscientists that drug addiction is not a moral failing on the part of the individual, it s a chronic disease of the brain and it can be treated. This isn t my opinion and is not a political statement and it really isn t open for debate because the evidence is clear and it s unequivocal. It s a fact born out by decades of study and research and it s a fact that neither the government nor the public can ignore. Gil Kerlikowske, Director of National Drug Control Policy Betty Ford Center June 12, 212
15 AMPHETAMINE DA DOPAC HVA Time After Amphetamine % of Basal Release Accumbens Time After Nicotine 3 hr COCAINE DA DOPAC HVA hr NICOTINE Accumbens Caudate Accumbens 4 % of Basal Release % of Basal Release % of Basal Release Effects of Drugs on Dopamine Release Accumbens 2 3 Time After Cocaine 4 5 hr MORPHINE Dose (mg/kg) Time After Morphine 4 Source: Di Chiara and Imperato (as adapted for National Institute on Drug Abuse Presentation) 5hr
16 Natural Rewards Elevate Dopamine Levels % of Basal DA Output Empty Box Feeding 6 FOOD 12 Time (min) NAc shell 18 DA Concentration (% Baseline) Scr Scr Bas Female 1 Present SEX Sample Number Scr Mounts Intromissions Ejaculations Scr Female 2 Present Copulation Frequency Source: Di Chiara et al. Source: Fiorino and Phillips
17 ADDICTION IS A dysregulation of the midbrain dopamine (salience/ reward) system due to unmanaged stress resulting in symptoms of decreased functioning. Specifically: 1. Loss of control 2. Craving 3. Persistent drug use despite negative consequences
18 TYPES OF CHRONIC DISEASES Hypertension Asthma Diabetes Addiction
19 Chronic Disease Treatment FOR EACH OF THE CHRONIC DISEASES LISTED, ANSWER THE FOLLOWING QUESTIONS: - WHAT IS THE TREATMENT - WHAT IS THE GOAL OF TREATMENT - WHAT HAPPENS IF THE PATIENT IS NONCOMPLIANT WITH TREATMENT -WHEN IS THE PATIENT DISCHARGED FROM TREATMENT
20 HARM REDUCTION Harm Reduction refers to a range of services that lessen the adverse consequences of drug use and protect public health. Unlike approaches that insist people stop using drugs, harm reduction acknowledges that many people are not able or are not willing to abstain from illicit drug use and that abstinence should not be a precondition for help.
21 ADDICTION CAREER Number of abstinent periods one month or longer followed by return to drug use prior to current abstinence* 5% reported 4 or more abstinent periods followed by a return to active addiction *Outside of controlled environment, among those who report one or more such periods: 71% N=248 Laudet & White 24
22 Recurrence Rates Are Similar for Addiction and Other Chronic Illnesses Percent of Patients Who Relapse to 5% 5 to 7% 5 to 7% Drug Dependence Type II Diabetes Hypertension Asthma Source: McLellan, A.T. et al., JAMA, Vol 284(13), October 4, 2.
23 Health Care Providers: Myths and Misperceptions
24 OPIOID ADDICTION First step is liking the drug or at least finding it eases emotional problems Endorphins and enkephalins relieve stress by making you feel warm, safe, fed and loved If you are a trauma survivor these drugs are especially appealing reinforcing the connection between the drug and life s fundamental comforts
25 Treatment For Opioid Use Disorders
26 MEDICATION ASSISTED RECOVERY The use of medication as prescribed and overseen by a physician knowledgeable about addiction care to support recovery from Substance Use Disorders (SUD).
27 TERMINOLOGY Dependence versus Substance Use Disorder (SUD) An SUD may occur with or without the presence of physical dependence. Physical dependence results from the body s adaptation to a drug or medication and is defined by the presence of Tolerance and/or Withdrawal
28 TREATMENT OPTIONS FOR INDIVIDUALS WITH OPIOID USE DISORDER Behavioral treatments educate patients about the conditioning process and teach recovery management strategies. Medications such as methadone and suboxone operate on the opioid receptors to relieve craving. Medications such as naltrexone block opioid receptor sites Combining the two types of treatment enables patients to stop using opioids and return to more stable and productive lives.
29 PURPOSE BEHIND USING MEDICATION WITH OPIOID USE DISORDER: Manage physical withdrawal symptoms Reduce risk of drug overdose Block any euphoric effect Facilitate therapeutic engagement Achieve long-term changes and prevent return to use
30 AGONIST A chemical that binds to a receptor site and triggers a response by the cell. They mimic the action of naturally occurring substances.
31 PARTIAL AGONISTS A chemical that binds and activates to a given receptor site but has only partial efficacy at the site relative to a full agonist. Buprenorphine Buprenex, Suboxone, Zubsolv, Subutex, Sublocade Probuphine Bunavail
32 OPIOID ANTAGONISTS Antagonist: Type of receptor ligand that does not provoke a biological response upon binding to a receptor but blocks agonist response. Naloxone Narcan Naltrexone ReVia, Vivitrol, Trexan
33 FULL AGONIST VS PARTIAL AGONIST
34 REVIEW OF DO S AND DON TS HANDOUT
35 EVIDENCE SUPPORTING METHADONE / BUPRENORPHINE MAINTENANCE
36 Heroin Abuse Frequency Vs. Methadone Dose % I.V. Drug Use Daily Dose In MGS. V.P. Dole, JAMA, VOL. 282, 1989, p. 1881
37 REDUCTION OF HEROIN USE BY LENGTH OF STAY IN METHADONE MAINTENANCE TREATMENT (BALL AND ROSS, 1991) N = 617
38 CRIME AMONG 491 PATIENTS BEFORE AND DURING MMT AT 6 PROGRAMS Crime Days Per Year Adapted from Ball & Ross - The Effectiveness of Methadone Maintenance Treatment, 1991
39 RETURN TO IV DRUG USE AFTER TERMINATION OF METHADONE MAINTENANCE TREATMENT Percentage In Tx Months Since Drop Out Ball, JC & Ross A The Effectiveness of Methadone Maintenace Treatment, Springer-Verlag, New York, 1991
40 MORTALITY RATES IN TREATMENT AND 12 MONTHS AFTER DISCHARGE ZANIS AND WOODY, 1998 % Died 1.% 9.% 8.% 7.% 6.% 5.% 4.% 3.% 2.% 1.%.% 1.% 8.2% In Treatment (n=397) Discharged (n=11) 4
41 I ve learned that people Will forget what you said, people will forget what you did but people will never forget how you made them feel. Maya Angelou
THE LANGUAGE OF RECOVERY
THE LANGUAGE OF RECOVERY Ed Johnson, M.Ed., MAC, LPC The Carolinas and Kentucky Program Manager Southeast Addiction Technology Transfer Center, HHS Region 4 www.attcnetwork.org/southeast EMail: edjohnson@msm.edu
More informationThe Biology of Addiction
The Biology of Addiction Risk factors for addiction: Biological/Genetic Family history of addiction Being male Having mental illness Exposure to substances in utero * The genes that people are born with
More informationLearning Objectives. Language Matters. Why Are We Here? Guiding Vision. Words 2/15/2019
Learning Objectives The Language of Recovery: How to Share the Reality of Recovery in Professional Settings Ed Johnson, M.Ed., MAC, LPC, CCS Associate Director, Training and Technical Assistance Southeast
More informationWhat Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016
What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationine) on (% Baseli Concentratio DA C
Chemical Dependency Relapse Pathways Relapse Prevention Medications Understanding the how, why, where and when. Acknowledgements La Hacienda Treatment Center American Society of Addiction Medicine National
More informationThe Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison
The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison Attitudes about addiction and recovery throughout history Disease?
More informationNATURE VS NURTURE. Heroin & Opioid Addictions Impact on Health & Wellbeing of Individuals, Families & Populations OVERVIEW OF PRESENTATION
Heroin & Opioid Addictions Impact on Health & Wellbeing of Individuals, Families & Populations OVERVIEW OF PRESENTATION Review of biology of addiction The Opioid Epidemic Impact on the individual Impact
More informationMedication-Assisted Treatment. What Is It and Why Do We Use It?
Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite
More informationListen & Hear 4Lo
Mark Lim M.D FASAM Medical Director NorthLakes Community Clinic Recovery Program Board Certified in Family Medicine Board Certified in Addiction Medicine mlim@northlakesclinic.org 7156852200 Listen & Hear
More informationImplementing Adolescent Recovery Supports & Developing Resources in our Communities
Implementing Adolescent Recovery Supports & Developing Resources in our Communities Reclaiming Futures Thursday, September 27th 11am PDT / 2pm EDT Click to edit Master title style Common Myths About Drug
More informationMedical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine
Medical Interventions for Addiction in Primary Care Settings R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine March 23, 2010 NIH Consensus on Drug Treatment Drug Addiction
More informationATTC Purpose. Goals for the Training. Ground Rules for the Training. A Request 2/15/2019
What s the Relationship Between Addiction Professionals Attitudes and Beliefs and Stigma, Overdose and Unsuccessful Opioid Treatment? Ed Johnson, M.Ed. MAC, LPC, CCS Associate Director, Training and Technical
More informationMedications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives
More informationBrain Health and Opioid Abuse
2018 Statewide Tribal Opioid Summit Brain Health and Opioid Abuse Healing From Opiate Addiction Requires Comprehensive Approaches Psychological, Socio-Cultural, and Biological Donald R. Vereen, Jr., M.D.,
More informationOpioid Treatment in North Carolina SEPTEMBER 13, 2016
Opioid Treatment in North Carolina SEPTEMBER 13, 2016 Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use among Past Year Users Aged 12 or Older: 2007 Source Where Respondent Obtained
More informationMedication Assisted Treatment
Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,
More informationAddiction 101. Steve Hanson - Associate Commissioner NYS OASAS
Addiction 101 Steve Hanson - Associate Commissioner NYS OASAS After lunch Psychopharmacology Lecture Basic Questions Why do people do drugs? Why can t/ won t some people stop? Realities 1. People like
More informationTHE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.
THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationUpdate on Medications for Tobacco Cessation
Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction
More informationAddiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer
Addiction to Opioids Marvin D. Seppala, MD Chief Medical Officer Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice Friday, September 30, 2016 26 y.o. female from South
More informationMedications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC
Medications for Opioid Use Disorder Charles Brackett, MD, MPH General Internal Medicine, DHMC Opioid Related Deaths are on the Rise in the US National Vital Statistics System Mortality File Deaths are
More informationBuilding capacity for a CHC response to Ontario's Opioid Crisis
Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC
More information2/21/2018. What are Opioids?
Opioid Crisis: South Carolina Responds Carolyn Bogdon, MSN, FNP-BC Coordinator for Emergency Department Medication Assisted Treatment Program Medical University of South Carolina Opioid Crisis: A Mounting
More informationWasted AN INTRODUCTION TO SUBSTANCE ABUSE
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationCo-Occurring Disorders & Drug Addiction Basics: Identifying, Listening & Linking
Co-Occurring Disorders & Drug Addiction Basics: Identifying, Listening & Linking Sherry Larkins, Ph.D UCLA Integrated Substance Abuse Program June 24, 2011 1 Roadmap Overview of Co-Occurring Disorders
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
More informationDisclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.
Evolving Treads in Medication Assisted Treatment Christopher J Davis D.O. CAADC, FASAM Medical Director, The Ranch of Pennsylvania Medical Director, Pyramid Healthcare Diplomate of The American Board of
More informationHARM REDUCTION & TREATMENT. Devin Reaves MSW
HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that
More informationAddressing Opiate Abuse
Addressing Opiate Abuse William B. Lawson, MD, PhD, DLFAPA Associate Dean of Health Disparities University of Texas at Austin Dell Medical School william.lawson@austin.utexas.edu Opioids Medications that
More informationRestoration of Parenting Ability Through Treatment for Substance Use Disorders
Restoration of Parenting Ability Through Treatment for Substance Use Disorders DEBRA M. BARNETT, MD Board Certified in General Psychiatry, Addiction Psychiatry, Geriatric Psychiatry, and Forensic Psychiatry
More informationArwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry
The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic
More informationMedication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford
Medication Assisted Treatment of an Opioid Use Disorder J. Craig Allen, MD. Medical Director, Rushford Learning objectives At the conclusion of this activity, participants will be able to: Understand
More informationTHE CHRONIC DISEASE OF ADDICTION. J.A. Samander, M.D.
THE CHRONIC DISEASE OF ADDICTION J.A. Samander, M.D. OBJECTIVES Review of chronic, relapsing model of addiction Comparison with other chronic diseases Lessons from patients Addiction 24.6 million adults
More informationAddiction as a Neuropsychiatric Medical Condition
Addiction as a Neuropsychiatric Medical Condition Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse 5 November 2009 Summary
More informationDeveloped and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services
Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services www.randallwebber.com MAT clients are still addicted Truth: MAT clients will experience withdrawal symptoms if they stop
More informationMedication-Assisted Treatment (MAT) Overview
Medication-Assisted Treatment (MAT) Overview 2014 Opiate Conference: Don t Get Me Started Hyatt Regency, Columbus, Ohio June 30-July 1, 2014 Christina M. Delos Reyes, MD Medical Consultant, Center for
More informationOpioid Use Disorder Treatment Initiation in Diverse Settings
Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures
More informationImproving Outcomes in Methadone Treatment
Improving Outcomes in Methadone Treatment Cognitive/Behavioral Treatment Contingency Management Michael J. McCann, MA Matrix Institute on Addictions COMP Symposium September 11, 2007 Overview of Presentation
More informationOpiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
More informationShawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine
[Patient-focused, evidence-based addiction treatment] Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine BrightView Health All Rights Reserved www.brightviewhealth.com
More informationEighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas
Eighth Edition Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas 1 < < < Evolution of our Human Brain: Spinal Cord to Diencephalon to Mammalian-Meso Cortex to Neo Cortex
More informationMethadone Maintenance 101
Methadone Maintenance 101 OTP/DAILY DOSING CLINICS - ANDREW PUTNEY MD Conflicts of Interest - Employed by Acadia HealthCare 1 Why Methadone? At adequate doses methadone decreases opioid withdrawal symptoms
More informationAnyone Can Become Addicted. Anyone.
Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.
More informationHarm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD
Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD Objectives Provide an overview of harm reduction by defining shared language and key terms. Collaboratively
More informationMEDICATION ASSISTED TREATMENT
MEDICATION ASSISTED TREATMENT MODULE 14 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER Medication Assisted Treatment Types of Medication Assisted Treatment: Methadone Naltrexone
More informationExpanding Access To Medication Assisted Treatment for Opioid Use Disorders to Patients in the Hospital
Expanding Access To Medication Assisted Treatment for Opioid Use Disorders to Patients in the Hospital August 28, 2018 Hosted by John A. Renner, Jr., MD, DLFAPA Professor of Psychiatry Boston University
More informationAssociate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical
Associate Medical Director of Addiction Medicine, Summa Physicians Inc., Akron, OH Medical Director Esper Treatment Center, Erie, PA Chief Medical Officer, Interval Brotherhood Home, Akron, OH Director
More informationVivitrol/Suboxone. Comparison Study Summary
Vivitrol/Suboxone Comparison Study Summary Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., & King, J. (2017). Comparative effectiveness of extended-release naltrexone versus
More informationTreatment of Substance Use Disorders in the Real World. Jessica M. Peirce, Ph.D. Johns Hopkins University School of Medicine
Treatment of Substance Use Disorders in the Real World Jessica M. Peirce, Ph.D. Johns Hopkins University School of Medicine Objectives identify the core components of the most common substance use disorder
More informationAetna s Initiative on the Opioid Epidemic
Aetna s Initiative on the Opioid Epidemic Christopher James D.O., M.P.H. Medical Director, BH- Mid-Atlantic Territory (JamesC1@aetna.com) July 23, 2017 HHS Data on Epidemic Every Day in the U.S. More than
More informationMedication-Assisted Treatment (MAT) for Opioid Use Disorders
Medication-Assisted Treatment (MAT) for Opioid Use Disorders Sybil Marsh MA MD FASAM Department of Family Medicine and Community Health Case Western Reserve University/UHCMC Learning Objective 1 Following
More informationMedication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.
Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction
More informationRemoving the Stigma from Substance Use Disorder. Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health
Removing the Stigma from Substance Use Disorder Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health Learning Objectives Recognize the impact of Stigma on getting
More informationKRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH
KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH IF THESE MOMS REALLY CARED ABOUT THEIR BABIES, THEY WOULD JUST QUIT Those who can quit, often do Addiction
More informationAgenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model
Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased
More informationAGENDA U.S. SURGEON GENERAL, VIVEK MURTHY MD 2/5/2019
FORMER U.S. SURGEON GENERAL, VIVEK MURTHY MD AN ESTIMATED 20.8 MILLION PEOPLE IN OUR COUNTRY ARE LIVING WITH A SUBSTANCE USE DISORDER. THIS IS SIMILAR TO THE NUMBER OF PEOPLE WHO HAVE DIABETES, AND 1.5
More informationU.S. SURGEON GENERAL, VIVEK MURTHY MD
FORMER U.S. SURGEON GENERAL, VIVEK MURTHY MD AN ESTIMATED 20.8 MILLION PEOPLE IN OUR COUNTRY ARE LIVING WITH A SUBSTANCE USE DISORDER. THIS IS SIMILAR TO THE NUMBER OF PEOPLE WHO HAVE DIABETES, AND 1.5
More informationMAT - ICAAD 2018 Ron Jackson, MSW, LICSW
The ATTC Network Ten Regional Centers northwest@attcnetwork.org www.attcnetwork.org/northwest phone. 206-685-4419 1107 NE 45 th St, Ste 120, Seattle, WA 98105 http://attcnetwork.org/northwest U.S. Opioid
More informationMethadone and Naltrexone ER
Methadone and Naltrexone ER Laura G. Kehoe, MD, MPH, FASAM Medical Director MGH Substance Use Disorder Bridge Clinic Assistant Professor of Medicine Harvard Medical School Disclosures Neither I nor my
More informationOpioid Use Disorders &Medication Treatment
Agency medical director comments Opioid Use Disorders &Medication Treatment Charissa Fotinos, MD, MSc Deputy Chief Medical Officer Washington State Health Care Authority Learning Objectives: 1) Review
More informationSteve Hanson Associate Commissioner New York State Office of Alcoholism & Substance Abuse Services
Understanding Alcohol Abuse and Addiction Steve Hanson Associate Commissioner New York State Office of Alcoholism & Substance Abuse Services Steve.hanson@oasas.state.ny.us Agenda Understanding Alcohol/Drug
More informationMedication Assisted Treatment as an alternative in Drug Courts*
Medication Assisted Treatment as an alternative in Drug Courts* National Drug Court Institute *portions of this presentation include adapted slides by Frances Levin, MD, Joshua Lee, MD, & Laurence Westreich,
More informationMedication Assisted Treatment:
Medication Assisted Treatment: A Training For Multidisciplinary Addiction Professionals Module III Medications 101 Goals for Module III This module reviews the following: Overview of three medications
More informationTHE STATE OF MEDICINE IN ADDICTION RECOVERY
OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,
More informationBrain, Pain, Opioids. John Hart, DO
Brain, Pain, Opioids CHANGE John Hart, DO 4 % Rule 1 UDS Pain score Contract & PMP Ask about addiction Ak Ask about tfunction As long as function increases, there is no upper limit to opioid UDS Pain
More informationThe Chronic Disease of Addiction Evidence and Lessons from Practice
The Chronic Disease of Addiction Evidence and Lessons from Practice Laura G. Kehoe, MD, MPH Medical Director, MGH Substance Use Disorders Unit Bridge Clinic Massachusetts General Hospital Assistant Professor
More informationOPIOID SUBSTITUTION THERAPY RISKS & BENEFITS
OPIOID SUBSTITUTION THERAPY RISKS & BENEFITS LEO O. LANOIE, MD, MPH, FCFP, CCSAM, ABAM, FISAM, MRO Dr. Leo Lanoie, 2017 DISCLAIMER In the past year I have accepted funds from Purdue for speaking OPIOID
More informationAddiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017
Addiction Overview Causes Consequences Treatments Methadone/Buprenorphine 101 April 1, 2017 Diane A. Rothon MD Why? would you listen to this presentation Review the definition and neurobiology of addiction
More informationThe Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.
The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner April 9, 2018 Words are important. If you want to care for something, you call it a flower. If you want to kill something, you call
More informationThe Importance of Psychological Treatment and Behavioral Support
The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding
More informationMark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC
Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01
More informationMAT in the Corrections Setting
MEDICATION ASSISTED TREATMENT AND CORRECTIONS Frank Filippelli, DO, PhD September 2017 MAT in the Corrections Setting Who Does This Affect? What is MAT and What is the Evidence of Efficacy? Emphasis on
More informationThe Social Worker s Role in Medication Assisted Treatment
The Social Worker s Role in Medication Assisted Treatment Rocky Ephraim Lucas, LICSW Behavioral Health Consultant, Kanawha City Health Center (Cabin Creek Health Systems) What is Medication-Assisted Treatment
More informationData Driven Strategies
Data Driven Strategies Full Task Force Meeting September 16, 2014 Review the problems Snapshot of local data Task Force goals Risk factors Breakout groups Prevention Intervention Treatment Recovery Words
More informationPennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story
Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Sarah Sharfstein Kawasaki, MD Director of Addictions Services, Pennsylvania Psychiatric
More informationPregnancy, MAT and Addiction
Pregnancy, MAT and Addiction Carl Christensen, MD, PhD, D-FASAM Clinical Associate Professor, OB Gyn & Psychiatry Wayne State University School of Medicine William Morrone, DO, MPH, DABAM Covenant Hospital
More informationCare in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities
Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Jeanette M. Tetrault, MD FACP FASAM Associate Professor of Medicine Program
More informationDiscover the Hope: Opiate Treatment and Recovery
Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of
More information11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no
Dean Drosnes, MD, FASAM Associate Medical Director Caron Treatment Centers ASAM Disclosure of Relevant Financial Relationships Date of Activity: Nov 3, 2016 Name Commercial Interests Relevant Financial
More informationBuprenorphine as a Treatment Option for Opioid Use Disorder
Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital
More information4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.
MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H. MEDICAL DIRECTOR, UNITYPOINT HEALTH MERITER/ NEWSTART ADJUNCT PROFESSOR, UNIVERSITY OF WISCONSIN MADISON
More information7/7/2016 Journal of the American Medical Association,
1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of
More informationMedication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.
Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation
More informationDisease or Willful Misconduct DEFINITION OF ADDICTION
Understanding Substance Abuse in Individuals with Developmental Disabilities: an Approach to Reducing Consequences Disease or Willful Misconduct Implication Therapeutic Approach Punitive Approach Judith
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationTreatment Team Approaches in Substance Abuse Treatment
Treatment Team Approaches in Substance Abuse Treatment PLANT A SEED AND WATCH IT GROW 2 Substance use disorders span a wide variety of problems arising from substance use, and cover 11 different criteria:
More informationOverview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone
Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone Alexander Y. Walley, MD, MSc Associate Professor of Medicine Director, Addiction Medicine Fellowship Boston University
More informationHARM REDUCTION LAUREN PREST ADDICTION PSYCHIATRY FELLOW 2018 UNIVERSITY OF UTAH HEALTH, 2018
HARM REDUCTION LAUREN PREST ADDICTION PSYCHIATRY FELLOW 2018 OBJECTIVES Define Harm reduction. Understand how harm reduction theory is applied clinically. Explore how to analyze the spectrum of Harm Reduction
More informationBuprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction
Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction The Problem The overdose death rate in Missouri and in the country has been rising for
More informationVivitrol Vs. Suboxone
Vivitrol Vs. Suboxone Vivitrol - Naltrexone Indicated for opiate dependence and alcohol withdrawal pure antagonist 380mg once every 4 weeks IM Peak plasma concentration in 2 hrs, followed by a second peak
More informationOpportunities for Opioid Safety and Community-Based Overdose Management
Opportunities for Opioid Safety and Community-Based Overdose Management DANTE COLLINS ERICA C. ERNST MAYA DOE-SIMKINS SEPTEMBER 13, 2013 Overview Prevalence & data Overdose prevention Making an overdose
More informationTopics of today s training
Extended Release Naltrexone Vivitrol Christopher J Davis D.O. CAADC, FASAM Medical Director, Brightwater Landing Medical Director, Pyramid Healthcare Diplomate of The American Board of Addition Medicine
More informationTalking with your doctor
SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may
More informationMedicated Assisted Treatment
Medicated Assisted Treatment Enhancing the Potential for Recovery Part I Diana Padilla Program Manager NeC-ATTC 2 Diana Padilla, RCR, CASAC-T padilla@ndri.org Diana Padilla is a program manager at NDRI-USA,
More informationMedication Assisted Treatment for Opioid Use Disorders and Veteran Populations
Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Kamala Greene Genece, Ph.D. VP, Clinical Director Phoenix Houses of New York Benjamin R. Nordstrom, M.D., Ph.D. President
More informationMedication Assisted Treatment (MAT): A Component of Comprehensive Treatment for Substance Use Disorders
Medication Assisted Treatment (MAT): A Component of Comprehensive Treatment for Substance Use Disorders Tennessee Substance Exposed Infants (SEI) Neonatal Abstinence Syndrome (NAS) Workgroup Nancy K. Young,
More informationThe science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
More information